This is a very rare eye disease that babies are born with or develop very early in life. It causes a loss of vision. It's a genetic condition, meaning it runs in families. It affects the cells in the retina, the part of the eye that helps us see.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Leber congenital amaurosis (LCA) is a group of inherited eye diseases that cause severe vision loss from birth or within the first year of life. They affect the retina, the light-sensing tissue at the back of the eye that turns light into signals the brain can use. When the retina's light-sensing cells do not develop or work properly, the eye itself can look normal while sending very little useful information to the brain. Parents often first notice that a baby does not seem to look at faces or follow objects, or that the eyes make wandering, jerky movements (nystagmus). Other common features include pupils that react slowly or not at all to light, sensitivity to bright light, strong farsightedness and eyes that do not point in the same direction. Many children press, poke or rub their eyes, which is so typical of LCA that it has its own name, the oculo-digital sign. LCA is rare, affecting roughly 2 to 3 of every 100,000 newborns, but it is one of the leading genetic causes of severe vision loss in infants. When similar vision loss begins between ages 1 and 5, it is usually called early-onset severe retinal dystrophy, part of the same spectrum. Despite the similar name, LCA is a different disease from Leber hereditary optic neuropathy, which affects the optic nerve and usually begins in young adulthood.
LCA is caused by changes in genes the retina needs to develop and work. More than 20 genes are involved. Some are needed to build the light-sensing cells (photoreceptors), some convert light into electrical signals, and some recycle the light-sensitive molecules the eye uses over and over. Even with modern testing, no genetic cause is found in about 20 to 30 percent of people. Most often LCA is inherited in an autosomal recessive pattern: a child is affected when they inherit a nonworking copy of the same gene from each parent. The parents are usually healthy carriers with normal vision and no family history, so a diagnosis often comes as a surprise. When both parents carry the same gene change, each pregnancy has a 1 in 4 chance of an affected child. Less often, a single changed copy is enough to cause LCA, either passed down from a parent or arising new in the child. Nothing a parent did during pregnancy causes LCA. In some children, LCA is part of a wider genetic syndrome that can also affect the kidneys, brain or other organs. Some genes can cause either eye-only LCA or one of these syndromes, which is one reason the exact gene matters.
Diagnosis usually starts with an eye specialist, often a pediatric ophthalmologist, examining a baby whose vision seems poor. In early infancy the retina can look normal on examination, so the key test is an electroretinogram (ERG). It records the retina's electrical response to flashes of light, usually through a contact lens or small sensor placed on or near the eye. In LCA, the response is absent or severely reduced. A normal ERG rules LCA out. Retinal imaging can add detail about which layers of the retina are affected. Genetic testing, usually a panel that checks many retinal genes at once, is the step that identifies the specific type. That matters in practical ways: it can help predict how vision may change, shows whether a gene-specific treatment or clinical trial is an option, and tells the family the chance of LCA in future children. Because some forms are part of a syndrome, the care team may also check development, the kidneys and other organs, especially if there are signs beyond the eyes.
For most forms of LCA, there is currently no treatment that restores the retina, so care focuses on making the most of the vision a person has and supporting development and independence. Glasses correct the strong farsightedness common in LCA. Low-vision aids, such as magnifiers, high-contrast and large-print materials, and screen readers, can make remaining vision more useful. Orientation and mobility training teaches safe independent travel, often with a cane, and many children learn Braille. Early intervention programs for babies with visual impairment help prevent the learning delays that can follow early vision loss. Limiting exposure to bright light can ease light sensitivity. One genetic type has an approved treatment. Voretigene neparvovec (Luxturna) is a gene therapy for people with two nonworking copies of the RPE65 gene confirmed by genetic testing who still have enough living retinal cells. A surgeon injects a working copy of the gene under the retina, one eye at a time on separate days. In the main trial, people aged 4 to 44 were able to find their way through an obstacle course in noticeably dimmer light a year after treatment, while untreated participants did not change. It does not restore normal sight, it is not recommended before 12 months of age, and as eye surgery it carries risks such as infection, retinal tears, raised eye pressure and cataract, along with strict short-term aftercare. RPE65 changes account for only a minority of LCA. Gene therapies and other approaches for other LCA genes are being studied in clinical trials, but none is yet approved in the United States. Genetic counseling helps families understand the specific type, the chance of LCA in other children and what testing options exist for future pregnancies.
Vision in LCA is usually severely limited from early life. Many children see well enough only to tell light from dark or to make out large shapes, and about a third have no light perception at all. For most people the level of vision stays fairly stable or changes slowly, though some types gradually worsen and a small number of children improve slightly in early childhood. The specific gene often helps the care team give a more individual outlook. With early support, children with LCA can learn, play, go to school and grow into independent adults. Specialized teachers for students with visual impairment, school accommodations, assistive technology and mobility training make a substantial difference. Families often benefit from connecting with other families and with organizations for people who are blind or have low vision. Regular eye care continues throughout life. Habitual eye poking and rubbing may contribute to keratoconus, a thinning and bulging of the clear front surface of the eye, so families are often encouraged to gently redirect it. Cataracts are also more common. Checkups look for these treatable problems, update glasses and aids, and keep track of new trials that may fit the person's genetic type.
Arrange a prompt evaluation with an eye specialist if a baby does not seem to look at faces or follow objects, or has wandering or jerky eye movements or pupils that do not respond to light. If LCA has already been diagnosed, ask about genetic testing if it has not been done, and ask whether new trials apply as research advances. Contact the eye care team soon if vision seems to be getting worse, vision becomes blurrier or more distorted, or the eyes become red, painful or cloudy. After gene therapy surgery, report signs of eye infection or inflammation, or new flashes, floaters or a shadow over the vision, to the surgical team right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Leber Congenital Amaurosis is like, what's helped you, or ask the community a question.